Director of Business Development, Enzymatics, US

BIO

Jeremy Gillespie gained a Ph.D in Biology and Biochemistry from the University of Bath and followed this up with a postdoc at Kansas State University and then lastly at the University of Bristol before crossing the divide into the commercial world. Currently he is the Business Development Director for Europe at Enzymatics. Prior to that, he was Group Product Manager for Genomics at Thermo Fisher Scientific where he was responsible for the development of the portfolio of Nucleic Acid Amplification products. He also held Marketing and Sales positions at Invitrogen and BD Clontech respectively.


MORE INFO

Enzymatics' webpage


 

Speaker at